India's bioeconomy has experienced significant growth, increasing from USD 166 billion in 2024 to USD 195 billion in 2025. This expansion is driven by diverse industries including biopharmaceuticals ...

Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.

The Minister credited BIRAC as a key catalyst in translating scientific research into commercially viable products.

While the deal makes strategic sense, integrating two distinct businesses and delivering profitability ahead of a potential ...

Biotechnology – and its potential space in South Dakota's economy – has been slowly developing nationwide for decades. With recent advancements in the state like the University of South Dakota ...

MENLO PARK, Calif.--(BUSINESS WIRE)--Synthekine Inc., an engineered cytokine therapeutics company, today announced the appointment of John A. Orwin as Chair of its Board of Directors. Mr. Orwin ...

Redmile Group increased its Nurix Therapeutics holding by 4,415,514 shares; the estimated trade value was $63.43 million based on quarterly average pricing. Meanwhile, the quarter-end position value ...

DALLAS, TX, UNITED STATES, February 14, 2026 /EINPresswire.com/ — Andrew Hillman announces the launch of the Andrew Hillman Grant for Biotech, a national ...

The Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with Nobel Prize-winning mRNA technology, the company announced Tuesday. The news is the ...

The U.S. Food and Drug Administration (FDA) refused to consider Moderna’s application for a new flu vaccine using mRNA technology, the company announced Tuesday, a decision that could delay the ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.